RARE vs WD · rev $350.0M vs P/E 26, rev $608.0M
Ultragenyx (RARE) versus Walker & Dunlop Inc (WD) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Walker & Dunlop Inc (WD) is a mortgage finance company listed on US.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Latest reported WD revenue for 2026-06-30 was $608.0M. Net income was $18.9M. WD currently screens at market cap $2.56B and trailing P/E 25.8.
RARE currently screens at market cap $2.79B. WD currently screens at market cap $2.56B and trailing P/E 25.8.
Not investment advice. Open the RARE and WD stock pages for the full models.
Not investment advice.